




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
AnalgesicsZhang,BinPaintransmissionpathwayNoxiousstimuliPGsK+、H+BK5-HTPrimaryafferentfibresnociceptorSpinalcordLimbicsystemSomato-sensorycortexmoodeffect,theaffectiveaspectofpainthesensoryaspectofpainDorsalhornseverepainOpioids(eg.Morphine)inflammatorypain
NSAIDs(eg.Aspirin)localanaesthesia
smoothmusclecolicanginapectorisinducedbycoronaryarteryspasm
trigeminalpainDrugtreatmentofpaincholinoceptor-blockingdrugsvasodilatordrugs(eg.Nitroglycerin)
CarbamazepineLocalanaestheticsCortexSpinalcordDorsalhornVentralcaudalthalamusPGsK+、H+BK5-HTNSAIDsOpioidsSitesofactionofdifferentdrugsNon-opioidformildpainPainpersistingorincreasingWeakOpioidsformoderatepainPainpersistingorincreasingStrongOpioidsforseverepainFreedomfromcancerpainNSAIDse.g.aspirin,acetaminophene.g.codeine,tramadole.g.morphine,fentanyl,methadoneWHOanalgesicladder
Threestepsanalgesiatherapyforcancerpatients
opioidanalgesics
(narcoticanalgesic,addictiveanalgesics)
Opium(阿片)
isthedriedexudateobtainedfromunripeseedpodsofthepoppyPapaver
somniferum,containingmorphine,codeine,andotheralkaloidsubstances.Opiate
(阿片劑)meansthatasubstanceisextractedfromopiumorissimilarinstructuretonaturalsubstancespresentinopium.Opioid
(阿片樣物質(zhì))isatermthatdesignatessubstancesthatarenotderivedfromopium.Itrefersparticularlytoopioidpeptides,i.e.endogenouscompoundsthatbindtoopioidreceptorsandmimictheeffectofmorphine-likecompounds.WidelyusetermOpium
Theflowerofpapaver
TheplantofjoyOpium(阿片)Opiate(阿片劑)MorphineCodeinePapaverine
……Opioid(阿片樣物質(zhì))Endogenousopioidpeptides:
Enkephalins
Endorphins
Dynorphins
Nociceptinandnocistatin
Endomorphin-1/2Others:1992~1993197319621975
analgesicsiteislaminaeIIIofperiventricularandperiaqueductalgrayareaputforward“receptors”foropiateanalgesicsinbrainisolatedthefirst“endogenousopioidpeptide”andnamedenkephalinClonedopioidreceptors:μ
κ
δResearchhistoryExtracellularCytoplasmicNH2HOOCOpioidreceptorsGprotein-coupledreceptors
ThecellularmechanismsPresynapticinhibition:activationofopioidreceptorsonpresynapticnerveterminals.Closeavoltage-gatedCa2+channel,decreaseCa2+input,andtherebyreducetransmitterrelease(Ach,NA,Glu,5-HT,P).Postsynapticinhibition:activationofpostsynapticopioidreceptors.OpenK+channelsonpostsynapticneurons,increaseK+output,andtherebycausehyperpolarizationandthusreducepostsynapticneuronalexcitability.SpinalcordDorsalhornenkephalinsCa2+Ca2+PresynapticterminalPostsynapticneuronenkephalins
enkephalins
PresynapticterminalPostsynapticneuronThecellularmechanismsmorphinePharmacologicalactionsCNSSmoothmuscles3.Cardiovascularsystem4.Others1.CNSeffects:principaleffectsAnalgesiaSedation&euphoriaRespiratorydepressionCoughsuppressionOthers:miosis,nausea,hormone
2.
Smoothmusclesystem
Gastrointestinalsystem
BiliarytractUrinarysystemgenitalsystem
orthostatichypotensionMechanisms:
releaseofhistaminevasomotorcenter3.Cardiovascularsystem(1)peripheralarterialandvenousdilatation(2)intracranialpressuresecondarytorespiratorydepressionClinicalusesAnalgesiaCardiacasthmaAntidiarrheaAntitussiveAnalgesia(severepain)
terminalcancermyocardialinfarctionrenalandbiliarycolic(atropine)trauma,burn,operationatregulartimeandquantityPulmonaryedema
dyspneaAcuteleftventriculardysfunctionshortofbreath(respiratorycenter)
CO2retentionanxietyanddistressAlveolarhypoventilationmorphineReducecardiacpreloadandafterloadReducethesensitivityoftherespiratorycentertoincreasedCO2SedationCardiacasthma
andmorphinetherapy
2.CardiacasthmaOpioidanalgesicdrugsMorphine(嗎啡)Codeine(可待因)Pethidine(哌替啶)Methadone(美沙酮)Fentanyl(芬太尼)Tramadol(曲馬多)absorptionexcretiondistributionfreedrugoralFirstpasseliminationsc.im.bloodliverplacentalfetuslittlecrosstheBBB,butenoughforitsfunctionmetabolismmorphine-6-glucuronidekidney,
breastiv.activeBioavailability25-30%Morphine美施康定(硫酸嗎啡控釋片)
1.強效,作用持續(xù)12hr。主要用于晚期癌癥患者第三階梯止痛。
2.抑制呼吸,可引起惡心、嘔吐、便秘及排尿困難,長期應(yīng)用可產(chǎn)生耐受性、身體依賴性和成癮性。Codeine1.hasahigher
oral
efficacy,demethylationtomorphine2.lowerefficacythanmorphine3.mainlyuseasantitussive,severe
drycough.
聯(lián)邦止咳露:麻黃堿+可待因+氯苯那敏+氯化銨注意事項抑制支氣管腺體分泌,使痰液粘稠難以咳出,不宜用于痰多粘稠者。連續(xù)應(yīng)用不宜
2周,因久用可成癮。7歲兒童禁用。Pethidine(dolantin)SyntheticsubstanceWeakerpotencythanMorphine,noantitussiveactionMoresedative,morerapidonsetandshorterduration(2-4h)thanmorphineMetabolite:normeperidine
convulsion
LyticcocktailMethadone
1.syntheticcompound,oralbioavailabilityis80%2.milderphysicalabstinencesyndrome3.routinelyusedindetoxificationofthemorphineandheroinaddictsFentanyl1.moreanalgesicpotentcythanmorphine:100times2.
rapidonsetandshortdurationofaction3.
fentanyl,alfentanil,remifentanil:adjunctivedrugforgeneralanaesthesia
4.breakthroughcancerpain:癌癥患者的突發(fā)性疼痛,突然出現(xiàn),不能被患者的常規(guī)疼痛治療方案緩解。口腔經(jīng)粘膜芬太尼拘櫞酸鹽
(OralTransmucosal
FentanylCitrate,OTFC)FentanyllollipopACTIQ
芬太尼口腔粘膜貼片
(Fentanylsublingualtablets)ABSTRAL
適應(yīng)證:年齡18歲以上,已連續(xù)24小時使用阿片類藥,對高劑量阿片類藥物耐受者。TramadolAtypicalopioidWeakμ
activation,alsointeractswithmonoaminergicsystemsAlternativetotraditionalopioidanalgesics(improvedsideeffectprofile)1.Tolerance2.Dependence
physicaldependence:withdrawalsyndrome
psychologicaldenpendence:
compulsivedrug-seekingbehaviorWhenareusedforthereliefofpain,toleranceanddependencearenotsignificantandprevalentproblemAdverseeffects3.Generaladverseeffects1Constipation5Respiratorydepression2Biliarycolic6Posturalhypotension3Nauseaandvomiting7Increasedintracranialpressure4Urinaryretention8Dysphoria4.AcuteMorphinePoisoningNaloxone1.competitivefullantagonistforopioidR(μ)2.Uses:opioidoverdose3.shortt1/2(1h),repeatedinjectionsContraindications
obstetriclabor,breastingperiod
obstructiveairwaydisease,bronchialasthma
headinjuriesseriouslyimpairedhepaticorrenalfunctionModeofadministrationofopioidsOraladministrationSublingualadministrationRectaladministrationIntravenousadministrationIntramuscularadministrationIntrathecalandepiduraladministrationTransdermalpatchadministrationPatientControlledAnalgesia
(病人自控鎮(zhèn)痛,PCA)Non-opioidanalgesicsIntroduction
Non-steroidalanti-inflammatorydrugs(NSAIDs)Antipyretic-analgesicandanti-inflammatorydrugsAspirin-likedrugs
共同作用機制:
Inhibitionofcyclo-oxygenaseenzymes(COX),andresultinginhibitionofthesynthesisofprostaglandins(PGs)花生四烯酸的代謝途徑及主要代謝產(chǎn)物的生物活性保護胃粘膜比較COX-1&COX-2生物學(xué)作用
COX-1COX-2類型結(jié)構(gòu)型(血管,腎臟,胃)誘導(dǎo)型作用保護胃粘膜調(diào)節(jié)血小板聚集發(fā)熱、疼痛、致炎調(diào)節(jié)外周血管阻力調(diào)節(jié)腎血流量作用類型生理性作用病理性作用NSAIDs
不良反應(yīng)解熱、鎮(zhèn)痛、抗炎【COXisoforms:】
COX-1COX-2productionConstitutiveInduciblefunctionsPhysiological:GIprotectionRegulationofplateletaggregationRegulationofkidneybloodflowRegulationofperipheralvascularresistance
Pathological:
InflammationPainFeverNSAIDseffectsSideeffectsTherapeuticeffects【ThreemajoractionsofNSAIDs】
AntipyreticeffectAnalgesiceffect
Anti-inflammatoryeffect
heatproductionheatdissipationpathogenandtoxinsneutrophilsendogenouspyrogens(ILs,TNF)setpointbodytemperaturecox
NSAIDsPGE2
(hypothalamus)AntipyreticeffectCharacteristics
①
Central
②“Elevated”temperature—reduced“Normal”temperature—noinfluenceClinicalapplications
symptomatictreatmentPaintransmissionpathwayNoxiousstimuliPGsK+、H+BK5-HTnociceptorSpinalcordLimbicsystemSomato-sensorycortexDorsalhornNSAIDsAnalgesiceffectCharacteristics①Peripheral(probablyalsoinhibitpainstimuliatasubcorticalsite)②mildtomoderatepain③NoaddictionorrespiratoryinhibitionClinicalapplications
①havegoodeffectsonchronicdullpain—headache,toothache,neuralgia,musclepain,arthralgia,dysmenorrhea
②arenotveryeffectivefortraumaticpain,severevisceralpain—myocardialinfarctionorrenalorbiliarycolic
Threestepsanalgesiatherapyforcancerpatients
Drug
location
mechanism
characteristics
representative
Analgesics
NSAIDs
CNSperiphery(+)opiumreceptor(-)PGsynthesismorphineaspirinpowerfuldullandsharppaininflammatorypaincauseeuphoriaandaddictionrespiratoryinhibitionmoderate
chronicdullpaincancerpainnotaddictive
no
respiratoryinhibition比較NSAIDs和嗎啡的鎮(zhèn)痛作用Mechanismofinflammation:
phospholipidsinjuryfactorPLA2
neutrophilic
arachidonicacidgranulocyte
cytokinesinduceCOX-2
(ILs,TNF)
PGs
inflammation(redness,swelling,heatandpain)Anti-inflammatoryeffect:AccordingtoselectivityforCOX:
①Non-selectiveCOXinhibitors ②SelectiveCOX-2inhibitorsAccordingtochemicalstructures:
【NSAIDsclassifications】化學(xué)分類非選擇性COX抑制藥選擇性COX-2抑制藥水楊酸類阿司匹林苯胺類對乙酰氨基酚吲哚類吲哚美辛依托度酸芳基丙酸類布洛芬芳基乙酸類雙氯芬酸烯醇酸類吡羅昔康美洛昔康吡唑酮類保泰松烷酮類奈丁美酮二芳基吡唑類塞來昔布二芳基呋喃酮類羅非昔布磺酰苯胺類尼美舒利
(1)Antipyretic-analgesiceffect(2)Anti-inflammatoryandantirheumaticeffects(3)Plateleteffect
Aspirin(Acetylsalicylicacid)
PGI2TXA2
Plateleteffect:
thrombosisinhibitionAATXA2PGI2
(-)plateletaggregationvasculardilation(+)platelet
aggregationvascularconstriction血小板血管內(nèi)皮
AATXA2PGI2
(-)plateletaggregationvasculardilation(+)platelet
aggregationvascularconstriction血小板血管內(nèi)皮
Aspirin小劑量thrombosisinhibition:AATXA2PGI2
(-)plateletaggregationvasculardilation(+)platelet
aggregationvascularconstriction血小板血管內(nèi)皮
Aspirin大劑量
AspirinirreversiblyacetylatesandblocksplateletCOX1→TXA2biosynthesis(-)→plateletaggregation(-)→thrombosis(-).TXA2↓LowdosethrombosisisinhibitedPGI2notaffected
TXA2↓HighdoseunbeneficialforthrombosisinhibitionPGI2↓Clinicaluses:
①lowdose(40~100mg)isrecommended
②preventthrombosis:
cardiacorbrainischemicdiseasesangioplasty(血管成形術(shù))coronaryarterybypassgrafting
③Pregnancy-inducedhypertensionsyndrome(PIH)【Adverseeffects】GastrointestinalsideeffectsDisturbanceofbloodcoagulationSalicylismreactionHypersensitivityreactionsReye’ssyndromeNephrotoxicity
SalicylismreactionLargedosage(>5g/d)headache,vertigo,nausea,vomiting,tinnitus,decreasedvisionandhearing;hyperpnea,acid-basedisturbance,insanity.Therapy:①aspirinmus
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年低溫儲運應(yīng)用設(shè)備項目合作計劃書
- 移動學(xué)習(xí)在2025年人力資源管理師考試中的應(yīng)用試題及答案
- 2025年滴眼劑機械項目發(fā)展計劃
- 2025至2030中國陽離子表面活性劑市場盈利預(yù)測分析與營銷前景研發(fā)報告
- 2025至2030中國鋁盤條行業(yè)發(fā)展形勢與前景產(chǎn)銷需求趨勢報告
- 2025至2030中國水務(wù)市場發(fā)展動向分析及投資規(guī)模研究報告
- 2025至2030中國導(dǎo)電安全鞋市場消費模式預(yù)測與運營格局研究報告
- 硬筆常識測試題及答案
- 2025-2030鼓泡流化床(BFB)鍋爐行業(yè)市場現(xiàn)狀供需分析及投資評估規(guī)劃分析研究報告
- 2025-2030魚油行業(yè)市場現(xiàn)狀供需分析及重點企業(yè)投資評估規(guī)劃分析研究報告
- 中班科學(xué)課件:《彩色的世界》
- 德勤業(yè)務(wù)管理流程優(yōu)化咨詢報告課件
- 深靜脈導(dǎo)管維護流程
- 錄音證據(jù)文字模版
- DL∕T 617-2019 氣體絕緣金屬封閉開關(guān)設(shè)備技術(shù)條件
- 沖壓作業(yè)機械類作業(yè)活動風(fēng)險分級管控清單
- TCVN-2622-越南建筑防火規(guī)范(中文版)
- 不負(fù)韶華只爭朝夕-一模考試反思 課件-2021-2022學(xué)年高中主題班會(共17張PPT)
- 什么是管壁厚度號Sch
- 液壓閥詳細(xì)講解課件
- DB13(J)∕T 256-2018 農(nóng)村氣代煤工程技術(shù)規(guī)程
評論
0/150
提交評論